• Home
  • Research
  • Lab members
  • Publications
  • Biography
  • In the News
  • Open positions
  • Contact us
  My Site

Epigenetic roots of long-lasting therapy (October 2022) 
Nature
Taking the tripping out of psychedelic medicine (October 2022)
Nature
The National Academies released the workshop proceedings "Exploring Psychedelics and Entactogens as Treatment of Psychiatric Disorders"  (September 2022)
NASEM
Alaina Jaster receives a Travel Award to attend the 2022 INRC meeting in Valencia, Spain (July 2022)
INRC
Jason Younkin selected by the VIPGB to receive an NIH-NIMH T32 fellowship (June 2022)
VIPBG
Maya Gaines-Smith selected by VCU-IMSD to receive an NIH R25 fellowship (May 2022)
VCU-IMSD
Psychedelics show promise in treating mental illness (November 2021)
Virginia Tech
Single dose of a psychedelic drug alters neuron's structure and gene environment (November 2021)
VCU News
Mario de la Fuente selected by the VIPBG to receive an NIH-NIMH T32 fellowship (November 2020)
VIPBG
Unlocking the mysteries and mechanisms behind psychedelics' antidepressant activity (January 2020)
VCU News
Magic mushrooms could one day "cure depression", scientists claim (November 2019)
The Sun
Could psychedelic drugs be a new treatment option for people with depression? (November 2019)
VCU News
Outstanding teaching award to Javier González-Maeso - VCU School of Medicine (September 2018)
VCU School of Medicine
Mario de la Fuente's exhibition a the King's College Science Gallery in London (September 2018)
Science Gallery
Justin Saunders receives the Notice of Award for his F30 fellowship from NIH-NIMH (September 2018)
NIMH
Urjita Shah selected to present at the 2018 ISSR meeting (July 2018)
Serotonin Club
VCU News: Improving brain function in schizophrenia patients (October 2017)
VCU News
Protecting cognition from antipsychotics (September 2017)
Science Signaling
Schizophrenia life sciences poster (September 2017)
Tocris
Antipsychotics' cognitive side effects have gene-expression underpinnings (August 2017)
Psych Congress Network
Combining science and art the Ingràvid festival in Barcelona
Varvara
Setas alucinógenas para reducir la depresión en enfermos terminales (April 2017)
El País
Nuevas estrategias para el tratamiento de la esquizofrenia (March 2017)
La Vanguardia
C&E News: Radiotracer helps neuroscientists study epigenetics in the brain (August 2016)
C&EN
Mario de la Fuente receives a NIDA Travel Award to attend the 2016 ISSR meeting (July 2016)
Serotonin Club
Arquitectos de la comunicación celular (March 2016)
Investigación y Ciencia
Neuroscience News: An alternative treatment target for schizophrenia (February 2016)
Neuroscience News
Medical Express News: Alternative treatment target for schizophrenia (February 2016)
MedicalXpress
VCU News: New research suggests alternative treatment target for schizophrenia (February 2016)
VCU News
Science Signaling Podcast: GPCR heteromers and schizophrenia (January 2016)
Podcast
Dr. González Maeso joins the Department of Physiology and Biophysics at VCU (July 2015) ​
VCU
Baremo para los fármacos antipsicóticos (September 2014)
Investigación y Ciencia
Comment to "Weighing the evidence for Class A GPCR dimers" (June 2014)
J Physiol
A vital new path for schizophrenia treatment (March 2013)
Drug Development
News and Views in Nature Neuroscience (September 2012)
News and Views
Comments of Schizophrenia Research Forum about bad behavior  of atypical antipsychotics (August 2012)
Schizophrenia Forum
Enzyme Inhibitor Might Benefit Schizophrenia Patients (August 2012)
Psychiatry News
Research Highlights in Nature Reviews Neuroscience (August 2012)
Nature Reviews Neuroscience
Boosting Antipsychotic Drugs (August 2012)
The Scientist
Epilepsy Drug Boosts Memory (August 2012)
MedPage
Research Highlights in Nature Medicine (September 2012)
Nature Medicine
Descubren la razón de la resistencia a los fármacos contra la esquizofrenia (September 2012)
El Diario Vasco
Nuevos Avances en las Bases Bioquímicas de la Esquizofrenia (October 2012)
Investigación y Ciencia
Leading Edge Previews (November 2011)
Cell
Desarrollan un método para predecir si un fármaco es antipsicótico (November 2011)
rtve
Clues Emerge About the Maternal Infection Risk Factor for Schizophrenia (February 2011)
Schizophrenia Forum
A complex in psychosis (March 2008)
News and Views
​Psychosis drug target (March 2008)
Nature Medicine
Double GPCR trouble (March 2008)
Nature Reviews Drug Discovery
​Double GPCR trouble (April 2008)
Nature Reviews Neuroscience
Serotonin-glutamate receptor complex offers new drug target for psychosis (June 2008)
Nature Reviews Neurology
5-HT and Glutamate receptors -- Unique Complex Linked to Psychosis (March 2008)
Schizophrenia Forum
Descubren una vía para el desarrollo de fármacos contra la esquizofrenia (March 2008)
CNN
Científicos de la UPV descubren una nueva vía para combatir la esquizofrenia (February 2008)
El Correo
Hallan un nuevo tratamiento contra la esquizofrenia (February 2008)
EiTB
Alucinógenos contra la esquizofrenia (February 2008)
La Razón
Schizophrenia develops a complex (March 2008)
SciBX
Descubren la manera en la que los alucinógenos actúan sobre el cerebro (February 2007)
ABC
Descubren por qué el LSD es alucinógeno (February 2007)
Clarín
LSD Study Probes Hallucinogen's Effect on Brain (January 2007)
Washington Post
How Hallucinogens Play Their Mind-Bending Games (January 2007)
Scientific American
Proudly powered by Weebly
  • Home
  • Research
  • Lab members
  • Publications
  • Biography
  • In the News
  • Open positions
  • Contact us